Filing Flows

Filing Flows › Perrigo (PRGO) › Recalls, complaints & regulation

Perrigo (PRGO): recalls and clinical trials

Perrigo (PRGO) beyond its filings: 0 recalls in the last 12 months (82 in five years, 1 Class I); 1 active clinical trial.

Latest recalls

Perrigo's latest quarter

Perrigo, Q3 2026: revenue $989M (-5% year over year), operating margin 2.3%, net loss $27.5M, operating cash flow $96.2M. The chart follows the revenue to costs, profit and cash.

Questions

Has Perrigo had any recalls?

82 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.

How many clinical trials does Perrigo have?

1 active study on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.